ReP USP - Resultado da busca

Filtros : "Mclaughlin, Vallerie V" Limpar

Filtros

Artigo de periodico
Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension (2023)
Hoeper, Marius M; Badesch, David B; Ghofrani, Hossein Ardeschir ; Gibbs, John Simon Russell; Gomberg-Maitland, Mardi; Mclaughlin, Vallerie V; Preston, Ioana R; Souza, Rogerio de ; Waxman, Aaron B; Grünig, Ekkehard
Source: New england journal of medicine. Unidade: FM
Subjects: HIPERTENSÃO PULMONAR, PROTEÍNAS RECOMBINANTES, FÁRMACOS (SISTEMA CARDIOVASCULAR), RESULTADO DE TRATAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HOEPER, Marius M et al. Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension. New england journal of medicine, v. 388, n. 16, p. 1478-1490, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/56025. Acesso em: 10 nov. 2024.
APA
Hoeper, M. M., Badesch, D. B., Ghofrani, H. A., Gibbs, J. S. R., Gomberg-Maitland, M., Mclaughlin, V. V., et al. (2023). Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension. New england journal of medicine, 388( 16), 1478-1490. doi:10.1056/NEJMoa2213558
NLM
Hoeper MM, Badesch DB, Ghofrani HA, Gibbs JSR, Gomberg-Maitland M, Mclaughlin VV, Preston IR, Souza R de, Waxman AB, Grünig E. Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension [Internet]. New england journal of medicine. 2023 ; 388( 16): 1478-1490.[citado 2024 nov. 10 ] Available from: https://observatorio.fm.usp.br/handle/OPI/56025
Vancouver
Hoeper MM, Badesch DB, Ghofrani HA, Gibbs JSR, Gomberg-Maitland M, Mclaughlin VV, Preston IR, Souza R de, Waxman AB, Grünig E. Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension [Internet]. New england journal of medicine. 2023 ; 388( 16): 1478-1490.[citado 2024 nov. 10 ] Available from: https://observatorio.fm.usp.br/handle/OPI/56025
Artigo de periodico
Results of an expert consensus survey on the treatment of pulmonary arterial hypertension with oral prostacyclin pathway agents (2020)
Mclaughlin, Vallerie V; Channick, Richard; Marco, Teresa De; Farber, Harrison W; Gaine, Sean; Galie, Nazzareno; Krasuski, Richard A; Preston, Ioana; Souza, Rogerio de ; Coghlan, J. Gerry
Source: Chest. Unidade: FM
Subjects: HIPERTENSÃO PULMONAR, QUESTIONÁRIOS, ARTÉRIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MCLAUGHLIN, Vallerie V et al. Results of an expert consensus survey on the treatment of pulmonary arterial hypertension with oral prostacyclin pathway agents. Chest, v. 157, n. 4, p. 955-965, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.chest.2019.10.043. Acesso em: 10 nov. 2024.
APA
Mclaughlin, V. V., Channick, R., Marco, T. D., Farber, H. W., Gaine, S., Galie, N., et al. (2020). Results of an expert consensus survey on the treatment of pulmonary arterial hypertension with oral prostacyclin pathway agents. Chest, 157( 4), 955-965. doi:10.1016/j.chest.2019.10.043
NLM
Mclaughlin VV, Channick R, Marco TD, Farber HW, Gaine S, Galie N, Krasuski RA, Preston I, Souza R de, Coghlan JG. Results of an expert consensus survey on the treatment of pulmonary arterial hypertension with oral prostacyclin pathway agents [Internet]. Chest. 2020 ; 157( 4): 955-965.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1016/j.chest.2019.10.043
Vancouver
Mclaughlin VV, Channick R, Marco TD, Farber HW, Gaine S, Galie N, Krasuski RA, Preston I, Souza R de, Coghlan JG. Results of an expert consensus survey on the treatment of pulmonary arterial hypertension with oral prostacyclin pathway agents [Internet]. Chest. 2020 ; 157( 4): 955-965.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1016/j.chest.2019.10.043

Digital Library of Intellectual Production of Universidade de São Paulo 2012 - 2024